Concepedia

Carly Kabelac

CK

6

Publications

433

Citations

6

H-Index

2020

Active since

Affiliations

Aetion (United States)(Current)

Quest Diagnostics (United States)

National Cancer Institute

LabCorp (United States)

Harvard University

Carly Kabelac is an author at Aetion (United States) specializing in covid-19, epidemiology, and clinical epidemiology.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

Raymond A. Harvey, Jeremy A. Rassen, Carly Kabelac et al. · JAMA Internal Medicine · 2021 · 282 citations · Full text

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

Jennifer M. Polinski, Andrew R. Weckstein, Michael Batech et al. · JAMA Network Open · 2022 · 58 citations · Full text

Effectiveness of the Single-Dose Ad26.COV2.S COVID Vaccine

Jennifer M. Polinski, Andrew R. Weckstein, Michael Batech et al. · 2021 · 31 citations · Full text

, , +17

Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection

Raymond A. Harvey, Jeremy A. Rassen, Carly Kabelac et al. · 2020 · 29 citations · Full text

Heparin‐modified alginate microspheres enhance neovessel formation in <scp>hiPSC</scp> ‐derived endothelial cells and heterocellular <i>in vitro</i> models by controlled release of <scp>vascular endothelial growth factor</scp>

Fabiola Munarin, Carly Kabelac, Kareen L. K. Coulombe · Journal of Biomedical Materials Research Part A · 2021 · 23 citations · Full text

Rows per page

1–5 of 6